(Press-News.org) LOS ANGELES (July 20, 2011) –Neurologist Michele Tagliati, MD, director of the Movement Disorders Program at Cedars-Sinai Medical Center, served on an elite international task force commissioned by the Movement Disorder Society to provide insights and guidance on deep brain stimulation for dystonia, an uncommon condition that causes sustained, sometimes crippling muscle contractions.
The resulting articles, describing the data reviewed and outlining the group's conclusions, recommendations and points to be addressed in future research, published online last month in a special supplement to the journal Movement Disorders.
With members from Asia, Europe and North and South America, the task force critically reviewed, discussed and debated current practice and research before reaching consensus on issues facing treatment professionals. The group included neurologists, neurosurgeons, neurophysiologists, neuropsychiatrists, neuropsychologists and nurses with expertise and experience in deep brain stimulation for dystonia.
Tagliati made major contributions to two articles reviewing postoperative issues: "Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations," and "Early Postoperative Management: Programming, Medication Changes, and Evaluations." He was the only member from the United States in the group studying post-surgical management of patients undergoing deep brain stimulation.
"We reviewed the research literally paper by paper and line by line to come up with these documents," he said. "We separated credible papers from less authoritative papers and tried to extract what we could define as reliable evidence, separating solid data from that which is not as strong. Deep brain stimulation was developed in Europe and later adopted in the United States and many of the experts are in Europe because they've done it for a longer time. It was an honor for me to be assigned a leadership role in this kind of effort."
Dystonia causes muscles to contract, with the affected body part twisting involuntarily. There are several types of dystonia, with symptoms ranging from mild to severe. The Food and Drug Administration approved deep brain stimulation as a therapy for certain treatment-resistant dystonias in 2003 after approving it for essential tremor in 1997 and Parkinson's disease in 2002. The procedure recently was approved on a limited basis for obsessive-compulsive disorder.
"The fantastic thing is that with a certain type of dystonia – young-onset dystonia – DBS is not just a good therapy, but it can be a miraculous therapy, and I don't hesitate to use that term," said Tagliati, who has studied deep brain stimulation for more than a decade. "We have videos that are mind-boggling because they show kids in wheelchairs, with very bad distortions, who become normal. Not 80 percent better. Normal. They go and play basketball."
The device consists of electrical leads implanted in the brain and a stimulator located near the collarbone. The stimulator is programmed with a remote, handheld controller to modulate abnormal nerve signals that cause the uncontrollable muscle contractions of dystonia. According to studies cited by the task force, the procedure provides sustained benefit for patients with dystonia for up to three years and evidence grows that positive outcomes may extend up to 10 years.
Tagliati said DBS therapy is not effective in all cases and device implantation and programming are not without risk. The mechanism and batteries themselves can be subject to failure, although newer devices and redundant power sources reduce these risks. "Our studies and the published article point out that adverse events occasionally occur with DBS, and these range from annoying to life-threatening, with speech abnormalities being the most common programming side effects. The article offers recommendations for predicting, reducing and dealing with adverse events."
Tagliati, who leads an educational course on deep brain stimulation programming every year at the American Academy of Neurology meetings, said the Movement Disorders articles define the current state of the art for this therapy for dystonia. The American Academy of Neurology is conducting a similar data review that may establish guidelines for those who treat dystonia with deep brain stimulation.
Tagliati and his counterpart at the University of California, Los Angeles – Jeff M. Bronstein, MD, PhD – recently led another panel of international experts in developing a consensus on key issues related to deep brain stimulation for Parkinson's disease. Their work, with insight and guidance for practitioners, was published in Archives of Neurology last October.
Dystonia is less common than Parkinson's disease – and has been more of a medical mystery, even among many movement disorders specialists. The principles of deep brain stimulation are similar for each disorder, but the devices are placed in slightly different locations. Proper placement and precise, individualized programming are critical to success, and Tagliati said many cases of seemingly "failed" therapy can be corrected through expert fine-tuning of the device, along with proper medication management.
"Doctors are taught how to measure electricity coming from the muscles or from the brain, but they know little about 'injecting' electricity as a therapy. With DBS, there was a clinical science that needed to be developed," said Tagliati, who became interested in the procedure while completing a fellowship in movement disorders with top experts in the field. He has devoted his career to advancing the science of programming of the stimulator.
"We're establishing at Cedars-Sinai a center of excellence where deep brain stimulation is viewed as a clinical science, with the latest standards of surgical placement, programming and medication management," he said. "We're bringing together the academic activities that will increase knowledge and understanding among treatment professionals while improving the quality of care for individual patients."
###
Tagliati has received honoraria for lectures from Medtronic, Inc., and consulting fees from St. Jude Medical, both of which produce deep brain stimulation technology. The task force was supported entirely by the Movement Disorder Society, an international professional society invested in the research and care of patients with movement disorders.
Cedars-Sinai movement disorders expert on international task force for dystonia treatment
2011-07-22
ELSE PRESS RELEASES FROM THIS DATE:
Computer simulations aid understanding of bacterial resistance against commonly used antibiotics
2011-07-22
A recent study into the interactions between aminoglycoside antibiotics and their target site in bacteria used computer simulations to elucidate this mechanism and thereby suggest drug modifications.
In the article, which will be published on July 21st in the open-access journal PLoS Computational Biology, researchers from University of Warsaw, Poland, and University of California San Diego, USA, describe their study of the physical basis of one bacterial resistance mechanism - mutations of the antibiotic target site, namely RNA of the bacterial ribosome. They performed ...
Chromosome number changes in yeast
2011-07-22
Researchers from Trinity College Dublin have uncovered the evolutionary mechanisms that have caused increases or decreases in the numbers of chromosomes in a group of yeast species during the last 100-150 million years. The study, to be published on July 21st in the open-access journal PLoS Genetics, offers an unprecedented view of chromosome complement (chromosome number) changes in a large group of related species.
A few specific cases of chromosome number changes have been studied in plants and animals, for example the fusion of two great ape chromosomes that gave ...
'Freaky mouse' defeats common poison
2011-07-22
HOUSTON -- (July 21, 2011) -- Over millennia, mice have thrived despite humanity's efforts to keep them at bay. A Rice University scientist argues some mice have found two ways to achieve a single goal -- resistance to common poison.
New research by Michael Kohn and colleagues, reported today in the online journal Current Biology, analyzes a genetic mutation that has given the ordinary European house mouse this extraordinary ability.
The gene in question, vkorc1, is present in all mammals and manages vitamin K. A mutation to vkorc1 makes mice resistant to warfarin, ...
Skin sentry cells promote distinct immune responses
2011-07-22
A new study reveals that just as different soldiers in the field have different jobs, subsets of a type of immune cell that polices the barriers of the body can promote unique and opposite immune responses against the same type of infection. The research, published online on July 21st by Cell Press in the journal Immunity, enhances our understanding of the early stages of the immune response and may have important implications for vaccinations and treatment of autoimmune diseases.
Dendritic cells serve as sentries of the immune system and are stationed at the body's ...
As agricultural riches waylay pollinators, an endangered tree suffers
2011-07-22
For the conservation of species, hostile territory might sometimes have its advantages. That's according to a study of pollen flow among trees found only in remnant patches of native Chilean forest. The data show that the pollinators those rare trees rely on can be waylaid by the abundance of resources found in agricultural lands. As a result, trees growing in native forest patches are more likely to mate successfully when separated by resource-poor pine plantations than by those more attractive farmlands.
The finding reported in the July 21st Current Biology, a Cell ...
With secondhand gene, house mice resist poison
2011-07-22
Since the 1950s, people have tried to limit the numbers of mice and rats using a poison known as warfarin. But, over the course of evolution, those pesky rodents have found a way to make a comeback, resisting that chemical via changes to a gene involved in vitamin K recycling and blood clotting. Now, researchers reporting online on July 21 in Current Biology, a Cell Press publication, show that European mice have in some cases acquired that resistance gene in a rather unorthodox way: they got it secondhand from an Algerian mouse.
"House mice not only have become resistant ...
Chemists create molecular flasks
2011-07-22
Chemical reactions happen all of the time: some things burn or rust, others react to light exposure--even batteries use chemical reactions to supply electricity. One of the big challenges chemists continually face is finding new ways to control these reactions or create conditions that promote desirable reactions and limit undesirable ones.
Recently, researchers at New York University demonstrated an ability to make new materials with empty space on the inside, which could potentially control desired and unwanted chemical reactions.
Mike Ward, of NYU's Department ...
Diamonds pinpoint start of colliding continents
2011-07-22
Washington, D.C.—Jewelers abhor diamond impurities, but they are a bonanza for scientists. Safely encased in the super-hard diamond, impurities are unaltered, ancient minerals that can tell the story of Earth's distant past. Researchers analyzed data from the literature of over 4,000 of these mineral inclusions to find that continents started the cycle of breaking apart, drifting, and colliding about 3 billion years ago. The research, published in the July 22, 2011, issue of Science, pinpoints when this so-called Wilson cycle began.
Lead author Steven Shirey at the ...
Chemists create molecular polyhedron -- and potential to enhance industrial and consumer products
2011-07-22
Chemists have created a molecular polyhedron, a ground-breaking assembly that has the potential to impact a range of industrial and consumer products, including magnetic and optical materials.
The work, reported in the latest issue of the journal Science, was conducted by researchers at New York University's Department of Chemistry and its Molecular Design Institute and the University of Milan's Department of Materials Science.
Researchers have sought to coerce molecules to form regular polyhedra—three-dimensional objects in which each side, or face, is a polygon—but ...
Link between competing phases in cuprates leads to new theory
2011-07-22
UPTON, NY - A team of scientists studying the parent compound of a cuprate (copper-oxide) superconductor has discovered a link between two different states, or phases, of that matter - and written a mathematical theory to describe the relationship. This work, appearing in the July 22, 2011, issue of Science, will help scientists predict the material's behavior under varying conditions, and may help explain how it's transformed into a superconductor able to carry current with no energy loss.
"The ultimate goal is to use what we learn to design copper-oxide materials with ...